Skip to content

A study comparing the benefits and adverse effects of two drugs (Clomipramine versus Dapoxetine) in treating married heterosexual men who present who ejaculate too soon

The efficacy and safety of Clomipramine Hydrochloride versus Dapoxetine Hydrochloride in Married Heterosexual Men with Premature Ejaculation: A Pragmatic, Randomized Controlled Trial.

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/09/009691
Enrollment
120
Registered
2017-09-11
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Premature Ejaculation

Interventions

Intervention1: Tab. Clomipramine Hydrochloride and Psychoeducation: Oral clomipramine (25 mg daily for 1st week and 25-50 mg for subsequent 5 weeks, depending on participantsâ?? preference). Psycho-e

Sponsors

Christian Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Married male Has active and stable sexual relationship with wife Age â?? 21 to 64 years Meets DSM-5 criteria for premature ejaculation after screening Heterosexual orientation Speaks either of these languages â?? Hindi, Bengali, English, Tamil, Telugu, Malayalam Agrees to have sexual intercourse at least once a week (or at least six times) over the study period Agrees not to use study medicines more than once a day

Exclusion criteria

Exclusion criteria: Comorbid major mental illness (Psychosis, Bipolar affective disorder, Major Depressive Disorder, Obsessive compulsive disorder); Active psychoactive substance use in dependence pattern (other than Nicotine); Uncontrolled or Untreated medical comorbidities (Diabetes, Hypertension, Hypothyroidism, Cardiac illness, renal disease); Current use of antipsychotic and antidepressant drugs, herbal medicines, phosphodiesterase type 5 inhibitors (for example, sildenafil); Use of either Dapoxetine or Clomipramine in the past; Any potential neurological, urological, or endocrine cause of PE; Scoring 3 or 4 on first two domains, 0 or 1 on the third domain, and 0 on the fourth domain of the Premature Ejaculation Profile (PEP);

Design outcomes

Primary

MeasureTime frame
1. Premature Ejaculation Profile (PEP) Scores on each domain plus Index score 2. Clinical global impression of change (CGI - C)Timepoint: 1. At the end of 6 weeks 2. Every week till 6 weeks

Secondary

MeasureTime frame
Antidepressant Side Effects Checklist (ASEC)Timepoint: 1. At the end of 6 weeks 2. Every week till 6 weeks;Discontinuation rates and reasons for discontinuationTimepoint: 1. At the end of 6 weeks 2. Every week till 6 weeks

Countries

India

Contacts

Public ContactDr Saumil Dholakia

Christian Medical College

dholakiasaumil@cmcvellore.ac.in9003910197

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026